Columnist Betty Vertin simply can't keep up with having a full-time job, being a caregiver to her sons with DMD, and just being a mom.

People with myotonic dystrophy in the U.S. use more healthcare resources and face higher costs than those without the disease ...

Weight and time are funny concepts. Most people, unless they’re trying to pick up a refrigerator or something else that’s ...

A regulatory committee has recommended that Duvyzat be approved in the European Union as a treatment for Duchenne muscular ...

It's been nearly two years since Elevidys, a gene therapy for Duchenne MD developed by Sarepta Therapeutics, was approved by ...

This year's Futures National Conference, hosted by CureDuchenne for the Duchenne and Becker MD communities, is scheduled to ...

Columnist Shalom Lim celebrates two years of his relationship with reflections on life, love, and his experience with ...

Lila is a Science Writer at BioNews. She completed her PhD in neuroscience at the University of Washington, where she studied ...

Columnist Patrick Moeschen highlights some key federal programs and pieces of legislation in the history of muscular dystrophy.